Hologic (HOLX) Stock Forecast & Price Target

Compare

993 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

HOLX Analyst Ratings

Moderate Buy

6 Buy

7 Hold

0 Sell

Based on 13 analysts giving stock ratings to

Hologic

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

HOLX Stock 12 Month Forecast

Average Price Target

$75.22

▲(12.20% Upside)

Based on 13 Wall Street analysts offering 12 month price targets for Hologic in the last 3 months. The average price target is $75.22 with a high forecast of $94.00 and a low forecast of $69.00. The average price target represents a 12.20% change from the last price of $67.04.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"56":"$56","95":"$95","65.75":"$65.8","75.5":"$75.5","85.25":"$85.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":94,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$94.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":75.22,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$75.22</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":69,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$69.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[56,65.75,75.5,85.25,95],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,66.61,68.71692307692308,70.82384615384615,72.93076923076923,75.03769230769231,77.14461538461538,79.25153846153846,81.35846153846154,83.46538461538461,85.57230769230769,87.67923076923077,89.78615384615384,91.89307692307692,{"y":94,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,66.61,67.27230769230769,67.93461538461538,68.59692307692308,69.25923076923077,69.92153846153846,70.58384615384615,71.24615384615385,71.90846153846154,72.57076923076923,73.23307692307692,73.89538461538461,74.5576923076923,{"y":75.22,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,66.61,66.79384615384615,66.97769230769231,67.16153846153846,67.34538461538462,67.52923076923076,67.71307692307693,67.89692307692307,68.08076923076923,68.26461538461538,68.44846153846154,68.63230769230769,68.81615384615385,{"y":69,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":81.24,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.56,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.33,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.09,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.14,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.39,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":61.38,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57.28,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.01,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.33,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.16,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66.61,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$94.00

Average Price Target$75.22

Lowest Price Target$69.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Jack Scalprey

TR | OpenAI - 4o

$72

Hold

7.40%

Upside

Reiterated

09/27/25

AI Generated ArticleAI Generated Article

Ryan Zimmerman

BTIG

―

Hold

―

Reiterated

09/25/25

Hologic's Growth Potential: Hold Rating Amidst Uncertainties and Transient Headwinds

Conor McNamara

RBC Capital

$87→$94

Buy

40.21%

Upside

Reiterated

09/02/25

Hologic (HOLX) Gets a Buy from RBC Capital

David Toung

Argus Research

$80

Buy

19.33%

Upside

Upgraded

08/18/25

Hologic upgraded to Buy from Hold at ArgusHologic upgraded to Buy from Hold at Argus

Andrew Brackmann

William Blair

―

Buy

―

Reiterated

08/13/25

Hologic's Growth Prospects and Valuation Underscore Buy Rating

Anthony Petrone

Mizuho Securities

$70→$75

Buy

11.87%

Upside

Reiterated

07/31/25

Hologic price target raised to $75 from $70 at MizuhoHologic price target raised to $75 from $70 at Mizuho

Vijay Kumar

Evercore ISI

$68→$69

Hold

2.92%

Upside

Reiterated

07/31/25

Hologic (HOLX) Gets a Hold from Evercore ISI

Patrick Wood

Morgan Stanley

$65→$69

Hold

2.92%

Upside

Reiterated

07/31/25

Morgan Stanley Sticks to Its Hold Rating for Hologic (HOLX)Hologic, Inc.’s Equal‐Weight rating is supported by a PT adjustment from 65 to 69.

Liza Garcia

UBS

$65→$70

Hold

4.42%

Upside

Reiterated

07/31/25

UBS Reaffirms Their Hold Rating on Hologic (HOLX)UBS analyst Elizabeth Garcia raised the price target on Hologic (NASDAQ: HOLX) to $70.00 (from $65.00) while maintaining a Neutral rating.

Casey Woodring

J.P. Morgan

$70→$80

Buy

19.33%

Upside

Reiterated

07/31/25

Hologic (HOLX) Gets a Buy from J.P. Morgan

Michael Matson

Needham

―

Hold

―

Reiterated

07/31/25

Hologic's Mixed Financial Outlook: Hold Rating Amid Growth Concerns and Margin Declines

Puneet Souda

Leerink Partners

$70

Hold

4.42%

Upside

Reiterated

07/31/25

Hologic's Hold Rating: Balancing Molecular Diagnostics Growth with Breast Health Challenges and External Headwinds

Michael Ryskin

Bank of America Securities

$64→$70

Hold

4.42%

Upside

Reiterated

07/18/25

Bank of America Securities Sticks to Their Hold Rating for Hologic (HOLX)

Patrick B Donnelly

Citi

―

Buy

―

Upgraded

07/09/25

Citi upgrades Hologic (HOLX) to a Buy

Mason Carrico

Stephens

$77→$70

Buy

4.42%

Upside

Reiterated

05/13/25

Hologic price target lowered to $70 from $77 at StephensHologic price target lowered to $70 from $77 at Stephens

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Jack Scalprey

TR | OpenAI - 4o

$72

Hold

7.40%

Upside

Reiterated

09/27/25

AI Generated ArticleAI Generated Article

Ryan Zimmerman

BTIG

―

Hold

―

Reiterated

09/25/25

Hologic's Growth Potential: Hold Rating Amidst Uncertainties and Transient Headwinds

Conor McNamara

RBC Capital

$87→$94

Buy

40.21%

Upside

Reiterated

09/02/25

Hologic (HOLX) Gets a Buy from RBC Capital

David Toung

Argus Research

$80

Buy

19.33%

Upside

Upgraded

08/18/25

Hologic upgraded to Buy from Hold at ArgusHologic upgraded to Buy from Hold at Argus

Andrew Brackmann

William Blair

―

Buy

―

Reiterated

08/13/25

Hologic's Growth Prospects and Valuation Underscore Buy Rating

Anthony Petrone

Mizuho Securities

$70→$75

Buy

11.87%

Upside

Reiterated

07/31/25

Hologic price target raised to $75 from $70 at MizuhoHologic price target raised to $75 from $70 at Mizuho

Vijay Kumar

Evercore ISI

$68→$69

Hold

2.92%

Upside

Reiterated

07/31/25

Hologic (HOLX) Gets a Hold from Evercore ISI

Patrick Wood

Morgan Stanley

$65→$69

Hold

2.92%

Upside

Reiterated

07/31/25

Morgan Stanley Sticks to Its Hold Rating for Hologic (HOLX)Hologic, Inc.’s Equal‐Weight rating is supported by a PT adjustment from 65 to 69.

Liza Garcia

UBS

$65→$70

Hold

4.42%

Upside

Reiterated

07/31/25

UBS Reaffirms Their Hold Rating on Hologic (HOLX)UBS analyst Elizabeth Garcia raised the price target on Hologic (NASDAQ: HOLX) to $70.00 (from $65.00) while maintaining a Neutral rating.

Casey Woodring

J.P. Morgan

$70→$80

Buy

19.33%

Upside

Reiterated

07/31/25

Hologic (HOLX) Gets a Buy from J.P. Morgan

Michael Matson

Needham

―

Hold

―

Reiterated

07/31/25

Hologic's Mixed Financial Outlook: Hold Rating Amid Growth Concerns and Margin Declines

Puneet Souda

Leerink Partners

$70

Hold

4.42%

Upside

Reiterated

07/31/25

Hologic's Hold Rating: Balancing Molecular Diagnostics Growth with Breast Health Challenges and External Headwinds

Michael Ryskin

Bank of America Securities

$64→$70

Hold

4.42%

Upside

Reiterated

07/18/25

Bank of America Securities Sticks to Their Hold Rating for Hologic (HOLX)

Patrick B Donnelly

Citi

―

Buy

―

Upgraded

07/09/25

Citi upgrades Hologic (HOLX) to a Buy

Mason Carrico

Stephens

$77→$70

Buy

4.42%

Upside

Reiterated

05/13/25

Hologic price target lowered to $70 from $77 at StephensHologic price target lowered to $70 from $77 at Stephens

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Hologic

1 Month

xxx

Success Rate

6/10 ratings generated profit

Average Return

+1.68%

upgraded a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of +1.68% per trade.

3 Months

xxx

Success Rate

5/10 ratings generated profit

Average Return

+3.59%

upgraded a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +3.59% per trade.

1 Year

Andrew CooperRaymond James

Success Rate

7/11 ratings generated profit

Average Return

+4.95%

reiterated a buy rating 5 months ago

Copying Andrew Cooper's trades and holding each position for 1 Year would result in 63.64% of your transactions generating a profit, with an average return of +4.95% per trade.

2 Years

xxx

Success Rate

5/10 ratings generated profit

Average Return

+9.98%

upgraded a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +9.98% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HOLX Analyst Recommendation Trends

Rating

May 25

Jun 25

Jul 25

Aug 25

Sep 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, HOLX has received 12 Buy Ratings, 16 Hold Ratings, and 0 Sell Ratings. HOLX average Analyst price target in the past 3 months is 75.22.

Each month's total comprises the sum of three months' worth of ratings.

HOLX Financial Forecast

HOLX Earnings Forecast

Next quarter’s earnings estimate for HOLX is $1.10 with a range of $1.05 to $1.11. The previous quarter’s EPS was $1.08. HOLX beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year HOLX has Preformed in-line its overall industry.

HOLX Sales Forecast

Next quarter’s sales forecast for HOLX is $1.03B with a range of $1.03B to $1.04B. The previous quarter’s sales results were $1.02B. HOLX beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year HOLX has Preformed in-line its overall industry.

HOLX Stock Forecast FAQ

What is HOLX’s average 12-month price target, according to analysts?

Based on analyst ratings, Hologic’s 12-month average price target is 75.22.

What is HOLX’s upside potential, based on the analysts’ average price target?

Hologic has 12.20% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is HOLX a Buy, Sell or Hold?

Hologic has a consensus rating of Moderate Buy which is based on 6 buy ratings, 7 hold ratings and 0 sell ratings.

What is Hologic’s price target?

The average price target for Hologic is 75.22. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $94.00 ,the lowest forecast is $69.00. The average price target represents 12.20% Increase from the current price of $67.04.

What do analysts say about Hologic?

Hologic’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of HOLX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Hologic (HOLX) Stock Forecast & Price Target

HOLX Analyst Ratings

HOLX Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Hologic

HOLX Analyst Recommendation Trends

HOLX Financial Forecast

HOLX Earnings Forecast

HOLX Sales Forecast

HOLX Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts